Research Grants
Comprehensive list of funded research projects and collaborations
NIH Funded Research
Drug Disposition in Liver Transplant Patients
NIH
12/1988 – 11/1991
$562,486
Co-investigator (PI: Gilbert J. Burckart)
Predicting Outcome in Alcoholic Liver Transplant Recipient
NIH K08AA00257/01
June 1998-May 2003
$659,791
Consultant (PI: Andrea DiMartini)
Pharmaceutical Industry Sponsored Research
Clinical Trial of FK 506 in Liver and Renal Transplant Patients
Fujisawa Pharmaceuticals
10/1988 to 9/1990
$90,000
Co-investigator (PI: Starzl)
Interaction of FK 506 and Fluconazole
Pfizer Pharmaceuticals
6/1992 to 5/1993
$100,000
Co-investigator (PI: Venkataramanan)
Recent Clinical Trials
Multicenter trial in Entercavir v/s Adefovir
Bristol-Myer Squibb
$72,000
Principal Investigator
Pharmacokinetics Study with Valganciclovir
Roche
$115,652
Principal Investigator
Phase IIB Study of ISA247 and Tacrolimus
Isotechnika Inc.
$197,613
Principal Investigator
Fujisawa Research Program
FK 506 Kinetics in Patients with Liver Disease
Fujisawa Pharmaceuticals
1994-1997
$75,621
Co-investigator (PI: Venkataramanan)
FK 506 Studies-Data Analysis
Fujisawa Pharmaceuticals
1995
$10,000
Co-investigator (PI: Venkataramanan)
Long-Term Results of Pediatric Liver Transplantation
Fujisawa
1998
$10,000
Co-PI (PI: Jorge Reyes)
Clinical Research Studies
Open Label Study of Neoral as Primary Immunsuppressant Therapy
Novartis Pharmaceuticals
1/1998-12/1999
$83,200
Principal Investigator
CellCept Study in Post-Liver Transplant Patients
Roche Pharmaceuticals
12/1998-12/2000
$141,627
Principal Investigator
Sirolimus for Primary Pancreatic Transplantation
Wyeth
$5,000
Principal Investigator